Elsevier

Journal of Affective Disorders

Volume 257, 1 October 2019, Pages 669-677
Journal of Affective Disorders

Review article
Early intervention for bipolar disorder – Do current treatment guidelines provide recommendations for the early stages of the disorder?

https://doi.org/10.1016/j.jad.2019.07.062Get rights and content

Highlights

  • Current guidelines for those with bipolar disorder (BD) have minimal recommendations for those in the early stages of the disorder.

  • For those recovering from their first manic episodes, the recommendations for maintenance treatment were based on severity, family history or patient choice.

  • There was a consistent recommendation to use second generation antipsychotics for treating acute mania among adolescents.

  • Future intervention studies should have a greater focus on those in the earlier stages of BD.

Abstract

Background

Interventions early in the course of bipolar disorder (BD) may have the potential to limit its functional and symptomatic impact. However, the implementation of specific early interventions for BD has been limited which may at least partly be due to the lack of guidelines focused on the early illness stages. We therefore aimed to review the current recommendations for early stage BD from clinical practice guidelines.

Methods

We searched PubMED and PsychINFO for clinical guidelines for BD published in the ten years prior to 1 November 2018. Recommendations from identified guidelines that addressed early stage BD or first episode mania were consolidated and compared. We also reviewed the guidelines relating to adolescents with BD to complement the guidelines related to those in the early illness course.

Results

We identified fourteen international and national guidelines on BD or affective psychoses. Most guidelines contained a separate section on adolescents, but only a few referred specifically to early stage BD. There were no consistent recommendations for early stage disorder, except with respect to the indications for maintenance medication treatments. For adolescents, there was a consistent recommendation for the use of second generation antipsychotics for treating acute mania.

Limitation

The main limitation is that the identified guidelines did not include primary data that clearly separated illness and developmental stages.

Conclusions

There is a lack of emphasis on early BD among widely-respected current clinical guidelines, likely reflecting the dearth of primary data. Future evidence or consensus-based recommendations could significantly inform clinical practice for this population.

Introduction

Bipolar disorder (BD) is the fourth most significant contributor to disability amongst adolescents and young adults (Gore et al., 2011) and has one of the highest rates of suicide amongst mental disorders (Chesney et al., 2014). Most adults with BD experience the onset of mood symptoms before their 20s (Geoffroy et al., 2013). While earlier diagnosis and rapid implementation of effective evidence-based treatment can improve outcomes for those with BD (Kessing et al., 2014), there is typically a significant delay of 5–10 years between symptom onset and diagnosis (Baldessarini et al., 2003, Post et al., 2010).

Earlier diagnosis and interventions (termed early intervention or EI) refer to strategies to allow prompt and timely access to care, with appropriate and comprehensive interventions that are tailored to the ‘stage’ of disorder (Vieta et al., 2018). Staging models have helped articulate the imperative for EI by combining characteristics such as severity and time course of symptoms and level of functioning in profiling individuals with BD (Berk et al., 2007a, b). Although staging models are a fairly new conceptualization, they can help clinicians to focus on the needs of persons with BD at different ‘disorder stages’ and potentially personalise treatment approaches. Staging models conceptualise interventions in earlier stages as preventing illness progression (Berk et al., 2011) and as minimising functional and cognitive impairment, thereby limiting illness-related disability (Berk et al., 2007a, McGorry et al., 2006). Although direct evidence for prevention of illness progression is limited, there is already evidence that interventions in earlier illness stages may be more effective than those in later illness stages (Joyce et al., 2016). Those with fewer lifetime episodes show greater treatment improvement with Cognitive Behavioural Therapy (CBT) (Scott et al., 2006) and psychoeducation (Colom et al., 2010b).

Although there are several definitions on defining stages for BD, we considered early stage BD to be those in the first few episodes of BD as recommended by the International Society of Bipolar Disorders (ISBD) Staging Task Force (Kapczinski et al., 2014). This taskforce considers early stages as those “at the first or the first few episodes and are in aggregate associated with better functioning after recovery”. and corresponds to Stage 2 disorder as outlined by Berk et al. (2007a) and Cosci and Fava (2013). Thus, we included those in the early course of BD, after their onset of clear mania or hypomania that define BD I or II. This should be contrasted with the earlier stages of BD described by Duffy (2014) and Post (2010) which include subthreshold states, a vulnerability for the disorders, internalising disorders and anxiety symptoms as being in the earlier illness stages. However, these syndromes would be better categorised as prodromes, precursor syndromes or states (Eaton et al., 1995) rather than the more accepted ISBD consensus definition of early stage BD.

Among those in an earlier illness course, interventions have had limited and sporadic uptake, especially in comparison to services for those with early psychosis (though the latter often include a proportion of people with bipolar psychosis). Persons with early stage BD receive treatment from a variety of clinical services (e.g., EI services, community mental health teams, youth services), none of which are specialists in bipolar care, thus treatments vary greatly. Although there is promising data that specialised mood disorder services have better treatment outcomes (Kessing et al., 2013), it is highly likely that generalist clinicians are likely to provide interventions for those in earlier stages of BD in most parts of the world. These clinicians need access to high quality clinical guidance to support the care of those with early stage BD.

While there are several clinical guidelines with regards to the care for persons with BD (Goodwin et al., 2016, Grunze et al., 2009,Grunze et al., 2010, Grunze et al., 2013b, Yatham et al., 2018), few relate to early stage disorder (or early in the course of the disorder). These guidelines typically categorise treatments based on acute (manic, depressive, mixed episodes) or maintenance phases, and interventions for children and adolescents may receive a separate mention (Goodwin et al., 2016, Grunze et al., 2009, Grunze et al., 2010, Grunze et al., 2013b, Yatham et al., 2018). However, those in early course of the disorder (early stage) are rarely considered. The guidelines relating to adolescents may be relevant to those in early stage disorder, as the categories are overlapping, given that the peak age of onset of the disorder is in the late teens (Lin et al., 2006). However, as a substantial proportion of those with BD will have an onset in adulthood (Geoffroy et al., 2013), there is a need for a focus on early stage or course of the disorder rather than a focus on age of the affected individuals alone.

Therefore, clinicians currently have limited guidance in providing care for clients with early stage BD despite their clinical needs and outcomes being different to those with established illness. Consequently, it is important to review and compile recommendations from current guidelines that are specific to those with early stage BD. A set of such recommendations could also identify gaps in current evidence and develop a roadmap for future research which could in-turn generate future evidence-informed guidelines. Thus, we aimed to scope the literature and summarise the recommendations from clinical guidelines pertaining to treatment for early stage with a secondary focus on adolescents with BD.

Section snippets

Methods

We conducted a comprehensive scoping review for clinical guidelines describing treatment for those with BD, mania or affective psychoses.

Results

The keywords search of the electronic databases yielded 823 potentially eligible articles, of which 30 articles met the final criteria for inclusion. This included two guidelines (the National Institute of Health and Care Excellence guideline for Bipolar Disorder - Guideline 185 (NICE) (National Collaborating Centre for Mental Health (UK), 2014) and Australian Clinical Guidelines for Early Psychosis (ACGEP) (Early Psychosis Guidelines Writing Group and EPPIC National Support Program, 2016)),

Discussion

In our review of the international and national guidelines on BD published in the last decade, we identified a relative lack of recommendations for early stage disorder. Among the fourteen guidelines, half did not have any specific recommendations for the early stages of BD. This indicates a clear evidence gap in the literature which is likely to be preventing optimal care of people with early stage BD. This stands in comparison to the focus on, and positive outcomes from 20 years of early

CRediT authorship contribution statement

Chia Ming Fang: Data curation, Writing - original draft. Sue Cotton: Conceptualization, Data curation, Writing - original draft. Kate Filia: Data curation, Writing - original draft. Mark Phelan: Writing - review & editing, Writing - original draft. Philippe Conus: Writing - review & editing, Writing - original draft. Sameer Jauhar: Writing - review & editing, Writing - original draft. Steven Marwaha: Writing - review & editing, Writing - original draft. Patrick D McGorry: Writing - review &

Declaration of Competing Interest

MFC, SC, KF, MP, PC, SJ, SM, CD and AR have no conflicts to declare.

Role of funding source

PM has received grant funding from the Colonial Foundation, the National Health and Medical Research Council of Australia, NARSAD, the Stanley Foundation, NIH, and the Australian and Victorian Governments. He has also received past unrestricted grant funding from Janssen-Cilag, Astra Zeneca, Bristol-Meyers Squibb, Eli Lilly, Novartis, and Pfizer, and honoraria for consultancy and teaching from Janssen-Cilag, Eli Lilly, Pfizer, Astra Zeneca, Roche, Bristol-Meyers Squibb, and Lundbeck. He is a

Acknowledgements

PM, SC, MB, CD and AR are supported by Australian NHMRC Fellowships.

References (54)

  • M. Berk et al.

    Setting the stage: from prodrome to treatment resistance in bipolar disorder

    Bipolar Disord.

    (2007)
  • M. Berk et al.

    Quetiapine v. lithium in the maintenance phase following a first episode of mania: randomised controlled trial

    Br. J. Psychiatry

    (2017)
  • M. Berk et al.

    Staging in bipolar disorder: from theoretical framework to clinical utility

    World Psychiatry

    (2017)
  • E. Chesney et al.

    Risks of all-cause and suicide mortality in mental disorders: a meta-review

    World Psychiatry

    (2014)
  • F. Colom et al.

    Has number of previous episodes any effect on response to group psychoeducation in bipolar patients? A 5-year follow-up post hoc analysis

    Acta Neuropsychiatr.

    (2010)
  • F. Colom et al.

    Has number of previous episodes any effect on response to group psychoeducation in bipolar patients? A 5-year follow-up post hoc analysis

    Acta Neuropsychiatr.

    (2010)
  • P. Conus et al.

    Pharmacological treatment in the early phase of bipolar disorders: what stage are we at?

    Aust. N. Z. J. Psychiatry

    (2006)
  • F. Cosci et al.

    Staging of mental disorders: systematic review

    Psychother. Psychosom.

    (2013)
  • R.S. Diler

    Paediatric Bipolar Disorder, A Global Perspective

    (2007)
  • A. Duffy

    Toward a comprehensive clinical staging model for bipolar disorder: integrating the evidence

    Can. J. Psychiatry

    (2014)
  • Australian Clinical Guidelines For Early Psychosis, 2nd Edition

    (2016)
  • W.W. Eaton et al.

    Prodromes and precursors: epidemiologic data for primary prevention of disorders with slow onset

    Am. J. Psychiatry

    (1995)
  • T.E. Elanjithara et al.

    Treatment of the early stages of bipolar disorder

    Adv. Psychiatric Treat.

    (2011)
  • R. Emsley et al.

    The South African Society of Psychiatrists (SASOP) treatment guidlelines for psychiatric disorders

    South Afr. J. Psychiatry

    (2013)
  • R.L. Findling et al.

    Efficacy, long-term safety, and tolerability of ziprasidone in children and adolescents with bipolar disorder

    J. Child Adolesc. Psychopharmacol.

    (2013)
  • K.N. Fountoulakis et al.

    The international college of neuro-psychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), part 3: the clinical guidelines

    Int. J. Neuropsychopharmacol.

    (2017)
  • G.M. Goodwin et al.

    Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the british association for psychopharmacology

    J. Psychopharmacol.

    (2016)
  • Cited by (16)

    • Elevation of C-reactive protein in adolescent bipolar disorder vs. anxiety disorders

      2022, Journal of Psychiatric Research
      Citation Excerpt :

      As with any biomarker, the following steps should be addressed: validation with larger cohorts (age- and gender-matched), incorporation of more covariates (e.g., medications, substance use, metabolic measures, stressors), performance of subgroup analyses (e.g., family history, mood state, age of onset, treatment response), definition of treatment responses, standardization of CRP assays (including frequency and timing of measurement), determination of effect sizes, and delineation of qualitative cutoffs (if needed) (Holland, 2016). Finally, although Post et al. (2020) reviewed many promising interventions, work is needed to investigate the implications of identifying patients during the prodromal BD (Chia et al., 2019; Singh and Rose, 2009; Van Meter et al., 2016). Prospective studies assessing the chronology of CRP elevation in BD will be necessary to inform the timing of its use as a diagnostic indicator, especially in the prodromal period.

    • Grouping affective psychoses in early intervention: Justification for specific treatment guidelines

      2022, Psychiatry Research
      Citation Excerpt :

      Combined with our previous observation of an affective and non-affective psychoses dichotomy (6), they bring support to the relevance of the affective psychosis concept as a practical way to group patients in order to develop guidelines in early intervention. Reducing the complexity of diagnosis may contribute to promote the development of early intervention strategies that are still largely lacking for affective psychoses (Chia et al., 2019; Conus and McGorry, 2002). This simpler grouping may be a complement to a completely dimensional approach where treatment would be constructed on the presence of each psychopathological domain, which has its limitations (Potuzak et al., 2012).

    • A narrative review of intervention in first-episode affective psychoses

      2021, Journal of Psychiatric Research
      Citation Excerpt :

      Despite these challenging issues, the early phase of affective psychoses remains understudied (Chia et al., 2019; Conus and McGorry, 2002). Moreover, affective psychoses are often included in larger studies on first-episode, failing to provide guidelines and intervention packages adapted to the specific needs of these patients (Chia et al., 2019; Marwaha et al., 2018). In addition, much of the available data on this sub-group of disorders has often focused on specific symptomatic phases, mainly first-episode mania (Chang et al., 2016; Conus and McGorry, 2002; Strakowski et al., 1996; Tohen et al., 2000a,b), and very few studies have explored the larger domain of First-Episode Affective Psychoses (FEAP).

    View all citing articles on Scopus
    View full text